Loading in 2 Seconds...
Loading in 2 Seconds...
Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?. Patient consent overview for participation in a research study coordinated by the American College of Radiology Imaging Network (ACRIN).
Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
Patient consent overview for participation in a research study coordinated by the American College of Radiology Imaging Network (ACRIN)
ACRIN is a member of the National Cancer Institute’s clinical trials cooperative group program and supports multi-center research related to medical imaging at over 100 participating institutions.
PET scans use a small amount of a radioactive drug, or tracer, to show differences between healthy tissue and diseased tissue.
The most commonly used tracer – and the one used for this study – is called FDG (fluorodeoxyglucuse).
The test is sometimes called an FDG-PET scan.What is a PET Scan?
The combination of PET/CT provides the most complete information about both anatomy (CT) and cell function (PET).
CT is a special type of X-ray machine that produces detailed images of the organ -- or anatomy -- of interest.What is a PET/CT Scan?
Following treatment, study participants will need to schedule follow-up doctor visits as their doctor recommends. Medical care and treatment information may be collected for 12 months after study enrollment.
Participation is voluntary and may be stopped at any time.Participation Requirements
Your condition worsens
You experience serious side effects from the chemotherapy treatment
The chemotherapy your doctor prescribes is not part of the study.
New information becomes available
The study is stopped early due to lack of funds or lack of patient participation.Participation Requirements cont.
Group A, Group B, or Group C
Participants in groups A and B will undergo:
3 PET/CT Scans
Participants in group C will undergo:
2 PET/CT scansStudy Procedures
Scans 1and 2 – will be performed within 14 days before the cancer treatment begins
Scan 3 – will be performedafter the first cycle of chemotherapy
Group B participants will undergo 3 PET/CT scans.
Scan 1 – will be performedbefore cancer treatment
Scan 2 – will be performedafter the first cycle of chemotherapy
Scan 3 – will be performedafter the second cycle of chemotherapyStudy Procedures cont.
If you chose not to participate:
PET/CT scans can still be done, however you would need to speak to your doctor about this and other options
The care you receive will not be affected.Research Trial Procedures
Help doctors learn more about how to best treat your type of cancer and if the chemotherapy treatment is working (after the 2nd cycle of chemotherapy)
Allow doctors to see if PET/CT scans can help identify lung cancer that has spread
Ultimately help doctors determine the best treatment for lung cancer patients.Benefits of Participation
Your doctor or research associate will discuss these with you in more detail.
The risk of side effect is associated with the following procedures:
CT ScansRisks Associated with Participation
If you are pregnant or plan to become pregnant you should not participate in this study due to reproductive risks.Risks Associated with Participation cont.
ACRIN Statistical Center
Food and Drug Administration (FDA)
National Cancer Institute (NCI)
Institutional Review Board (IRB).Patient Confidentiality cont.
Contact the study doctor or research associate
Regarding patients’ rights:
Ask your study doctor or research associate for an Institutional Review Board (IRB) contact
Regarding general cancer research:
Call the NCI’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).If you have questions…